Kodiak Sciences Stock Forecast
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 8, 2:47 PM ET
KOD analyst consensus
Consensus (7 analysts)
strong_buy
Avg. price target
$116.67+24.97%
- Strong buy 1
- Buy 5
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Kodiak Sciences (2026-10-07), 6 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $116.67, with a high estimate of $145.00 and a low estimate of $96.00. The average target implies upside of 25.0% from the current price of $93.36.
The spread between the highest and lowest targets is 51.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for KOD.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 14% |
| Buy | 5 | 71% |
| Hold | 1 | 14% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $96.00 | +2.83% |
| Average target | $116.67 | +24.97% |
| High target | $145.00 | +55.31% |